ProQR Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio13.5222.0556.74210.75167.32
P/B Ratio2.983.513.714.433.04
Price/Tangible Book2.983.513.694.403.02
Price/FCF7.21
Price/OCF6.75
Enterprise Value Ratios
EV/Revenue9.557.6340.19158.93115.23
EV/FCF2.49
Profitability & Returns
Return on Equity (ROE)-0.43%-0.51%-0.71%-0.72%-0.62%
Return on Assets (ROA)-0.12%-0.14%-0.21%-0.23%-0.29%
Return on Capital Employed (ROCE)-0.24%-0.34%-0.43%-0.31%-0.57%
Leverage & Solvency Ratios
Debt/Equity0.190.480.330.530.61
Debt/FCF0.98
Liquidity Ratios
Current Ratio3.963.547.366.947.77
Quick Ratio3.893.517.246.837.44
Efficiency Ratios
Asset Turnover0.130.040.020.010.01
Yield & Distribution Ratios
Earnings Yield-0.11%-0.19%-0.26%-0.12%-0.27%
FCF Yield-0.14%0.14%-0.28%-0.05%-0.28%
Buyback Yield-0.06%-0.13%-0.12%-0.28%-0.22%